Search Results - "MUSHER, D. M"

Refine Results
  1. 1

    Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with Metronidazole by Musher, Daniel M., Aslam, Saima, Logan, Nancy, Nallacheru, Srikanth, Bhaila, Imran, Borchert, Franziska, Hamill, Richard J.

    Published in Clinical infectious diseases (01-06-2005)
    “…Background Clostridium difficile is a frequent cause of serious nosocomial infection. Earlier reports have suggested that treatment with metronidazole cured…”
    Get full text
    Journal Article
  2. 2

    Spinal and paraspinal pneumococcal infections—a review by Siddiq, D. M., Musher, D. M., Darouiche, R. O.

    “…Spinal and paraspinal infections caused by Streptococcus pneumoniae remain a rare event. We present two cases from our institution, discuss the…”
    Get full text
    Journal Article
  3. 3

    Diagnostic Value of Microscopic Examination of Gram-Stained Sputum and Sputum Cultures in Patients with Bacteremic Pneumococcal Pneumonia by Musher, Daniel M., Montoya, Roberto, Wanahita, Anna

    Published in Clinical infectious diseases (15-07-2004)
    “…Clinicians continue to question the usefulness of microscopic examination of Gram-stained sputum specimens ("Gram staining") and sputum culture for diagnosis…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Infections Caused by Streptococcus pneumoniae: Clinical Spectrum, Pathogenesis, Immunity, and Treatment by Musher, D M

    Published in Clinical infectious diseases (01-04-1992)
    “…Serious pneumococcal infection is most prevalent in the extreme ages of life. A high incidence of pneumococcal bacteremia has repeatedly been documented in…”
    Get full text
    Journal Article
  6. 6

    Diagnosis and management of pulmonary infection due to Rhodococcus equi by Lin, W.V., Kruse, R.L., Yang, K., Musher, D.M.

    Published in Clinical microbiology and infection (01-03-2019)
    “…Rhodococcus equi is a recognized cause of disease in humans, especially in individuals who are immunocompromised. Because diphtheroids are regarded as part of…”
    Get full text
    Journal Article
  7. 7

    Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (“Streptococcus milleri Group”) Are of Different Clinical Importance and Are Not Equally Associated with Abscess by Clarridge, Jill E., Attorri, Silvia, Musher, Daniel M., Hebert, Jeff, Dunbar, Sherry

    Published in Clinical infectious diseases (15-05-2001)
    “…Difficulties in distinguishing organisms of the “Streptococcus milleri group” (SMG; Streptococcus intermedius, Streptococcus constellatus, and Streptococcus…”
    Get full text
    Journal Article
  8. 8

    Association of Invasive Pneumococcal Disease with Season, Atmospheric Conditions, Air Pollution, and the Isolation of Respiratory Viruses by Kim, Paul E., Musher, Daniel M., Glezen, W. Paul, Barradas, Maria C. Rodriguez, Nahm, Walter K., Wright, Charles E.

    Published in Clinical infectious diseases (01-01-1996)
    “…We examined the relation of invasive pneumococcal disease to season, atmospheric conditions, and the rate of respiratory virus isolation in a community-wide…”
    Get full text
    Journal Article
  9. 9

    Association Between FcγRIIa-R131 Allotype and Bacteremic Pneumococcal Pneumonia by Yee, Arthur M. F., Phan, Hoang M., Zuniga, Ricardo, Salmon, Jane E., Musher, Daniel M.

    Published in Clinical infectious diseases (01-01-2000)
    “…Human FcγRIIa has 2 codominantly expressed allotypes, which differ greatly in their ability to ligate immunoglobulin G2 (IgG2). Whereas FcγRIIa-R131 binds only…”
    Get full text
    Journal Article
  10. 10

    Clinical prediction rules in community-acquired pneumonia: lies, damn lies and statistics by Abers, M S, Musher, D M

    Published in QJM : An International Journal of Medicine (01-07-2014)
    “…A variety of prediction scores have been developed to identify at the time of presentation patients with community-acquired pneumonia at risk for intensive…”
    Get full text
    Journal Article
  11. 11

    Response of Human Immunodeficiency Virus–Infected Patients Receiving Highly Active Antiretroviral Therapy to Vaccination with 23-Valent Pneumococcal Polysaccharide Vaccine by Rodriguez-Barradas, Maria C., Alexandraki, Irene, Nazir, Tabinda, Foltzer, Michael, Musher, Daniel M., Brown, Sheldon, Thornby, John

    Published in Clinical infectious diseases (01-08-2003)
    “…Whether highly active antiretroviral therapy (HAART) impacts responses to 23-valent pneumococcal polysaccharide vaccine (PV) is not known. Immunoglobulin G…”
    Get full text
    Journal Article
  12. 12

    The Association between Pneumococcal Pneumonia and Acute Cardiac Events by Musher, Daniel M., Rueda, Adriana M., Kaka, Anjum S., Mapara, Sulaiman M.

    Published in Clinical infectious diseases (15-07-2007)
    “…Background. Increased cardiac stress, hypoxemia, and inflammation may contribute to acute cardiac events, such as myocardial infarction (MI), arrhythmia,…”
    Get full text
    Journal Article
  13. 13

    Impact of an antibiotic restriction program on antibiotic utilization in the treatment of community-acquired pneumonia in a Veterans Affairs Medical Center by Mansouri, M. D, Cadle, R. M, Agbahiwe, S. O, Musher, D. M

    Published in Infection (01-02-2011)
    “…Purpose The impact of an antibiotic restriction program (ARP) on the patterns of antibiotic use in the treatment of community-acquired pneumonia (CAP) was…”
    Get full text
    Journal Article
  14. 14

    The Potential Role for Protein-Conjugate Pneumococcal Vaccine in Adults: What Is the Supporting Evidence? by Musher, Daniel M., Sampath, Rahul, Rodriguez-Barradas, Maria C.

    Published in Clinical infectious diseases (01-03-2011)
    “…Vaccination with protein-conjugate pneumococcal vaccine (PCV) provides children with extraordinary protection against pneumococcal disease, although the…”
    Get full text
    Journal Article
  15. 15

    Analysis of mutations in the pbp genes of penicillin-non-susceptible pneumococci from Turkey by Biçmen, M., Gülay, Z., Ramaswamy, S.V., Musher, D.M., Gür, D.

    Published in Clinical microbiology and infection (01-02-2006)
    “…Sequence analysis of the pbp genes from 20 Streptococcus pneumoniae isolates from Turkey (eight with high-level penicillin-resistance, nine with low-level…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Does active hepatitis C virus infection increase the risk for infection due to Staphylococcus aureus? by Kaka, A. S., Filice, G. A., Kuskowski, M., Musher, D. M.

    “…Infections with Staphylococcus aureus may be more frequent in subjects with active hepatitis C virus (HCV) infection. In this retrospective dual-cohort study,…”
    Get full text
    Journal Article
  18. 18

    Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users by Amendola, A, Tanzi, E, Zappa, A, Colzani, D, Boschini, A, Musher, D.M, Zanetti, A.R

    Published in Vaccine (01-11-2002)
    “…The immunogenicity of 23-valent pneumococcal polysaccharide vaccine was assessed in 57 HIV-1 infected former intravenous drug users and in 20 HIV-1 negative…”
    Get full text
    Journal Article
  19. 19

    Fluid-containing emphysematous bullae: a spectrum of illness by Chandra, D, Rose, S. R, Carter, R. B, Musher, D. M, Hamill, R. J

    Published in The European respiratory journal (01-08-2008)
    “…Fluid-containing emphysematous bullae are an under-reported complication of chronic obstructive pulmonary disease. The roles of bronchoscopy in the work-up and…”
    Get full text
    Journal Article
  20. 20

    Nitazoxanide for the Treatment of Clostridium difficile Colitis by Musher, Daniel M., Logan, Nancy, Hamill, Richard J., DuPont, Herbert L., Lentnek, Arnold, Gupta, Arvind, Rossignol, Jean-Francois

    Published in Clinical infectious diseases (15-08-2006)
    “…Background. Clostridium difficile colitis has increased in incidence and severity, and treatment failure with metronidazole therapy has increasingly been…”
    Get full text
    Journal Article